Patent details

EP1451192 Title: NOVEL CRYSTALLINE COMPOUND

Basic Information

Publication number:
EP1451192
PCT Application Number:
PCT/IB/2002/004948
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP027815893
PCT Publication Number:
WO/2003/048162
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL CRYSTALLINE COMPOUND
French Title of Invention:
NOUVEAU COMPOSE CRISTALLIN
German Title of Invention:
NEUE KRISTALLINE VERBINDUNG
SPC Number:

Dates

Filing date:
25/11/2002
Grant date:
09/02/2011
EP Publication Date:
09/02/2011
PCT Publication Date:
12/06/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/09/2004
EP B1 Publication Date:
09/02/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/11/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/11/2002
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, CT 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/02/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LI Zheng Jane, Pfizer Global R. & D.
Address:
United States (US)

2

Name:
FLANAGAN Mark Edward, Pfizer Global R. & D.
Address:
United States (US)

Priority

Priority Number:
338984 P
Priority Date:
06/12/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/04;

Publication

Bulletin

Bulletin Heading:
VB2
Bulletin edition number:
2019/03
Publication date:
22/02/2019
Description:
Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

European Patent Bulletin

Issue number:
201807
Publication date:
14/02/2018
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
19/10/2021
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages